Shasun Pharmaceuticals (Delisted) financials and balance sheet

BSE: 524552

Formerly Shasun Chemicals and Drugs

Last traded ₹428.55 on 17 Nov 2015

Delisted on 21 Apr 2016.

8 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Shasun Pharmaceuticals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 1 of the 8 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2009, the company's revenue for that year, ₹472 Cr, differs from its quarters added, ₹488 Cr.

Results for the year to Mar 2015

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue1,078
  2. Operating expenses−966
  3. Operating profit113
  4. Depreciation−37
  5. Other income+14
  6. One-off items+1.5
  7. Finance costs−46
  8. Profit before tax46
  9. Tax−4.5
  10. Net profit41

Profit and loss

Standalone, ₹ crore, years to March.Shasun Pharmaceuticals quarterly results

₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Revenue from operations4824725495687367839351,078
429472490529684715845966
Materials and goods bought278275310382469485542628
Employee costs–––––77––
Other expenses–––––153––
Operating profit before depreciation5205939526889113
Operating margin10.9%0.0%10.8%6.9%7.0%8.7%9.6%10.5%
Materials, % of revenue–––––62.0%––
Employee costs, % of revenue–––––9.8%––
Other expenses, % of revenue–––––19.5%––
Depreciation and amortisation2727262425323837
Operating profit after depreciation26−27331527365176
Other income5231441141214
Finance costs712162230263646
Profit before one-off items and tax–−3820837242844
One-off items–––––––1
Profit before tax24−3820837242846
Tax2−4−23−16−3−74
Net profit22−3322553263541
Net margin4.6%−7.1%4.0%0.9%7.2%3.4%3.8%3.8%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2008, Mar 2009, Mar 2010, Mar 2011, Mar 2012, Mar 2014 and Mar 2015 they do not, so they are left blank.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Earnings per share₹4.61−₹6.91₹4.57₹1.00₹10.92₹4.76–₹6.94
Diluted earnings per share–−₹6.90₹4.56₹1.00₹10.76₹4.76–₹6.77
Market cap at the year end (₹ crore)217612452524053653992,240

Ratios

Standalone, years to March.

RatioMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Revenue growth––16.5%3.4%29.6%6.4%19.4%15.4%
Operating profit growth–––−33.8%31.5%32.3%31.3%26.2%
Net profit growth–––−77.9%987.1%−50.5%34.1%17.3%
Earnings per share growth–––−78.1%992.0%−56.4%––
Interest cover3.9–2.10.70.91.41.41.7
Interest cover is left blank for the year to Mar 2009: operating profit after depreciation is a loss, and a loss covers no interest bill. Revenue growth is left blank for the year to Mar 2009: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2015.

Measure5 years3 years
Revenue growth, yearly rate14.4%13.6%
Profit growth, yearly rate13.4%−8.0%
Operating margin, average8.5%9.6%
Net margin, average3.8%3.7%
Interest cover, average1.21.5

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015
Effective tax ratePublished threshold 17.16 per cent−8.7238.15−42.38−11.17−26.059.78
A threshold marked as ours has no published figure; it is the line we read the check against.